Annual EBITDA
-$19.88 M
+$11.83 M+37.30%
31 December 2023
Summary:
Imunon annual earnings before interest, taxes, depreciation & amortization is currently -$19.88 million, with the most recent change of +$11.83 million (+37.30%) on 31 December 2023. During the last 3 years, it has risen by +$1.42 million (+6.65%). IMNN annual EBITDA is now -1315.63% below its all-time high of -$1.40 million, reached on 01 September 1996.IMNN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.66 M
-$53.50 K-1.16%
30 September 2024
Summary:
Imunon quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.66 million, with the most recent change of -$53.50 thousand (-1.16%) on 30 September 2024. Over the past year, it has dropped by -$1.38 million (-42.03%). IMNN quarterly EBITDA is now -790.83% below its all-time high of $674.00 thousand, reached on 01 June 2013.IMNN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$20.04 M
-$1.38 M-7.38%
30 September 2024
Summary:
Imunon TTM earnings before interest, taxes, depreciation & amortization is currently -$20.04 million, with the most recent change of -$1.38 million (-7.38%) on 30 September 2024. Over the past year, it has increased by +$8.24 million (+29.15%). IMNN TTM EBITDA is now -4591.66% below its all-time high of -$427.10 thousand, reached on 01 June 1999.IMNN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.3% | -42.0% | +29.1% |
| 3 y3 years | +6.7% | +9.7% | +0.1% |
| 5 y5 years | +6.4% | +6.0% | -20.3% |
IMNN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +37.3% | -42.0% | +67.7% | -7.4% | +36.8% |
| 5 y | 5 years | -20.1% | +37.3% | -42.0% | +67.7% | -21.1% | +36.8% |
| alltime | all time | -1315.6% | +37.3% | -790.8% | +67.7% | -4591.7% | +36.8% |
Imunon EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.66 M(+1.2%) | -$20.04 M(+7.4%) |
| June 2024 | - | -$4.60 M(-3.1%) | -$18.66 M(-3.8%) |
| Mar 2024 | - | -$4.75 M(-21.2%) | -$19.39 M(-2.5%) |
| Dec 2023 | -$19.88 M(-37.3%) | -$6.03 M(+83.9%) | -$19.88 M(-29.7%) |
| Sept 2023 | - | -$3.28 M(-38.5%) | -$28.28 M(-8.3%) |
| June 2023 | - | -$5.33 M(+1.8%) | -$30.85 M(-1.4%) |
| Mar 2023 | - | -$5.24 M(-63.7%) | -$31.29 M(-1.3%) |
| Dec 2022 | -$31.70 M(+51.8%) | -$14.43 M(+146.7%) | -$31.70 M(+40.1%) |
| Sept 2022 | - | -$5.85 M(+1.4%) | -$22.62 M(+3.2%) |
| June 2022 | - | -$5.77 M(+2.0%) | -$21.93 M(+3.5%) |
| Mar 2022 | - | -$5.65 M(+5.7%) | -$21.19 M(+1.5%) |
| Dec 2021 | -$20.88 M(-2.0%) | - | - |
| Dec 2021 | - | -$5.35 M(+3.7%) | -$20.88 M(+4.1%) |
| Sept 2021 | - | -$5.16 M(+2.4%) | -$20.06 M(-10.2%) |
| June 2021 | - | -$5.03 M(-5.7%) | -$22.33 M(+1.0%) |
| Mar 2021 | - | -$5.34 M(+18.0%) | -$22.11 M(+3.8%) |
| Dec 2020 | -$21.30 M(+28.7%) | -$4.53 M(-39.1%) | -$21.30 M(+0.6%) |
| Sept 2020 | - | -$7.43 M(+54.4%) | -$21.16 M(+13.3%) |
| June 2020 | - | -$4.81 M(+6.2%) | -$18.68 M(-3.0%) |
| Mar 2020 | - | -$4.53 M(+3.1%) | -$19.25 M(+16.3%) |
| Dec 2019 | -$16.55 M(-22.0%) | -$4.39 M(-11.3%) | -$16.55 M(-0.6%) |
| Sept 2019 | - | -$4.95 M(-8.0%) | -$16.65 M(+4.6%) |
| June 2019 | - | -$5.38 M(+194.4%) | -$15.93 M(-14.7%) |
| Mar 2019 | - | -$1.83 M(-59.3%) | -$18.67 M(-12.1%) |
| Dec 2018 | -$21.23 M(+7.5%) | -$4.49 M(+6.4%) | -$21.23 M(-0.7%) |
| Sept 2018 | - | -$4.22 M(-48.0%) | -$21.38 M(-5.6%) |
| June 2018 | - | -$8.13 M(+85.2%) | -$22.66 M(+17.9%) |
| Mar 2018 | - | -$4.39 M(-5.4%) | -$19.22 M(-2.7%) |
| Dec 2017 | -$19.76 M(-2.7%) | -$4.64 M(-15.7%) | -$19.76 M(+0.1%) |
| Sept 2017 | - | -$5.50 M(+17.3%) | -$19.74 M(-3.1%) |
| June 2017 | - | -$4.69 M(-4.8%) | -$20.37 M(+2.4%) |
| Mar 2017 | - | -$4.93 M(+6.5%) | -$19.88 M(-2.1%) |
| Dec 2016 | -$20.31 M(-1.8%) | -$4.63 M(-24.5%) | -$20.31 M(-2.5%) |
| Sept 2016 | - | -$6.13 M(+45.7%) | -$20.82 M(+12.4%) |
| June 2016 | - | -$4.21 M(-21.4%) | -$18.53 M(-5.1%) |
| Mar 2016 | - | -$5.35 M(+4.2%) | -$19.53 M(-5.6%) |
| Dec 2015 | -$20.68 M(-13.1%) | -$5.14 M(+33.9%) | -$20.68 M(-3.7%) |
| Sept 2015 | - | -$3.83 M(-26.3%) | -$21.48 M(-10.8%) |
| June 2015 | - | -$5.20 M(-20.0%) | -$24.08 M(-4.4%) |
| Mar 2015 | - | -$6.50 M(+9.6%) | -$25.20 M(+5.9%) |
| Dec 2014 | -$23.80 M(+240.1%) | -$5.93 M(-7.8%) | -$23.80 M(+11.7%) |
| Sept 2014 | - | -$6.44 M(+1.8%) | -$21.31 M(+13.9%) |
| June 2014 | - | -$6.32 M(+23.9%) | -$18.71 M(+59.8%) |
| Mar 2014 | - | -$5.10 M(+48.1%) | -$11.71 M(+67.3%) |
| Dec 2013 | -$7.00 M(-73.0%) | -$3.45 M(-10.1%) | -$7.00 M(-39.3%) |
| Sept 2013 | - | -$3.83 M(-668.5%) | -$11.52 M(-14.5%) |
| June 2013 | - | $674.00 K(-271.4%) | -$13.48 M(-33.2%) |
| Mar 2013 | - | -$393.20 K(-95.1%) | -$20.19 M(-22.1%) |
| Dec 2012 | -$25.93 M(+15.0%) | -$7.97 M(+37.6%) | -$25.93 M(+7.9%) |
| Sept 2012 | - | -$5.79 M(-4.1%) | -$24.03 M(-2.2%) |
| June 2012 | - | -$6.04 M(-1.4%) | -$24.58 M(-0.7%) |
| Mar 2012 | - | -$6.13 M(+0.9%) | -$24.74 M(+11.8%) |
| Dec 2011 | -$22.55 M | -$6.07 M(-4.1%) | -$22.13 M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$6.34 M(+2.1%) | -$20.60 M(+6.2%) |
| June 2011 | - | -$6.20 M(+76.2%) | -$19.39 M(+23.0%) |
| Mar 2011 | - | -$3.52 M(-22.5%) | -$15.77 M(-6.0%) |
| Dec 2010 | -$18.62 M(+17.9%) | -$4.54 M(-11.5%) | -$16.78 M(+12.5%) |
| Sept 2010 | - | -$5.13 M(+98.8%) | -$14.91 M(+3.0%) |
| June 2010 | - | -$2.58 M(-43.1%) | -$14.48 M(-13.4%) |
| Mar 2010 | - | -$4.53 M(+69.6%) | -$16.71 M(+6.0%) |
| Dec 2009 | -$15.79 M(+36.4%) | -$2.67 M(-43.1%) | -$15.77 M(+7.0%) |
| Sept 2009 | - | -$4.70 M(-2.3%) | -$14.73 M(+2.7%) |
| June 2009 | - | -$4.81 M(+34.1%) | -$14.35 M(+21.2%) |
| Mar 2009 | - | -$3.59 M(+119.3%) | -$11.84 M(-3.6%) |
| Dec 2008 | -$11.58 M(-11.9%) | -$1.64 M(-62.1%) | -$12.28 M(-4.1%) |
| Sept 2008 | - | -$4.32 M(+88.1%) | -$12.81 M(+4.3%) |
| June 2008 | - | -$2.30 M(-43.1%) | -$12.28 M(-12.3%) |
| Mar 2008 | - | -$4.04 M(+86.4%) | -$14.00 M(+7.4%) |
| Dec 2007 | -$13.14 M(+33.6%) | -$2.16 M(-42.8%) | -$13.03 M(+3.7%) |
| Sept 2007 | - | -$3.78 M(-5.9%) | -$12.57 M(+11.9%) |
| June 2007 | - | -$4.02 M(+31.2%) | -$11.24 M(+17.0%) |
| Mar 2007 | - | -$3.06 M(+79.7%) | -$9.61 M(-0.4%) |
| Dec 2006 | -$9.84 M(+2.5%) | -$1.71 M(-30.3%) | -$9.65 M(-5.1%) |
| Sept 2006 | - | -$2.45 M(+2.4%) | -$10.16 M(+3.7%) |
| June 2006 | - | -$2.39 M(-23.0%) | -$9.80 M(-2.0%) |
| Mar 2006 | - | -$3.11 M(+39.9%) | -$10.00 M(+6.8%) |
| Dec 2005 | -$9.60 M(-35.5%) | -$2.22 M(+6.5%) | -$9.36 M(-10.3%) |
| Sept 2005 | - | -$2.08 M(-19.4%) | -$10.44 M(-12.0%) |
| June 2005 | - | -$2.59 M(+4.7%) | -$11.87 M(+8.5%) |
| Mar 2005 | - | -$2.47 M(-25.1%) | -$10.94 M(-25.1%) |
| Dec 2004 | -$14.87 M(+12.7%) | -$3.30 M(-5.9%) | -$14.60 M(+2.6%) |
| Sept 2004 | - | -$3.51 M(+111.4%) | -$14.23 M(-1.3%) |
| June 2004 | - | -$1.66 M(-72.9%) | -$14.42 M(-7.5%) |
| Mar 2004 | - | -$6.13 M(+108.8%) | -$15.59 M(+9.6%) |
| Dec 2003 | - | -$2.94 M(-20.5%) | -$14.23 M(+7.7%) |
| Sept 2003 | -$13.20 M(+35.4%) | -$3.69 M(+30.4%) | -$13.20 M(+17.2%) |
| June 2003 | - | -$2.83 M(-40.7%) | -$11.27 M(+2.0%) |
| Mar 2003 | - | -$4.77 M(+149.3%) | -$11.05 M(+10.3%) |
| Dec 2002 | - | -$1.91 M(+8.7%) | -$10.02 M(+2.7%) |
| Sept 2002 | -$9.76 M(+35.2%) | -$1.76 M(-32.7%) | -$9.76 M(-6.4%) |
| June 2002 | - | -$2.61 M(-30.1%) | -$10.42 M(+10.0%) |
| Mar 2002 | - | -$3.74 M(+127.1%) | -$9.47 M(+28.8%) |
| Dec 2001 | - | -$1.65 M(-32.2%) | -$7.35 M(+2.4%) |
| Sept 2001 | -$7.22 M(+48.6%) | -$2.43 M(+46.1%) | -$7.18 M(+9.6%) |
| June 2001 | - | -$1.66 M(+2.5%) | -$6.55 M(+9.5%) |
| Mar 2001 | - | -$1.62 M(+10.1%) | -$5.98 M(+8.7%) |
| Dec 2000 | - | -$1.47 M(-18.1%) | -$5.50 M(+11.6%) |
| Sept 2000 | -$4.86 M(+102.4%) | -$1.80 M(+64.3%) | -$4.93 M(+23.4%) |
| June 2000 | - | -$1.09 M(-4.2%) | -$4.00 M(+20.0%) |
| Mar 2000 | - | -$1.14 M(+26.7%) | -$3.33 M(+52.1%) |
| Dec 1999 | - | -$900.00 K(+4.3%) | -$2.19 M(+69.8%) |
| Sept 1999 | -$2.40 M(-39.8%) | -$862.90 K(+102.0%) | -$1.29 M(+202.0%) |
| June 1999 | - | -$427.10 K | -$427.10 K |
| Sept 1998 | -$3.99 M(+68.3%) | - | - |
| Sept 1997 | -$2.37 M(+68.8%) | - | - |
| Sept 1996 | -$1.40 M | - | - |
FAQ
- What is Imunon annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Imunon?
- What is Imunon annual EBITDA year-on-year change?
- What is Imunon quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Imunon?
- What is Imunon quarterly EBITDA year-on-year change?
- What is Imunon TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Imunon?
- What is Imunon TTM EBITDA year-on-year change?
What is Imunon annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IMNN is -$19.88 M
What is the all time high annual EBITDA for Imunon?
Imunon all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.40 M
What is Imunon annual EBITDA year-on-year change?
Over the past year, IMNN annual earnings before interest, taxes, depreciation & amortization has changed by +$11.83 M (+37.30%)
What is Imunon quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IMNN is -$4.66 M
What is the all time high quarterly EBITDA for Imunon?
Imunon all-time high quarterly earnings before interest, taxes, depreciation & amortization is $674.00 K
What is Imunon quarterly EBITDA year-on-year change?
Over the past year, IMNN quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.38 M (-42.03%)
What is Imunon TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IMNN is -$20.04 M
What is the all time high TTM EBITDA for Imunon?
Imunon all-time high TTM earnings before interest, taxes, depreciation & amortization is -$427.10 K
What is Imunon TTM EBITDA year-on-year change?
Over the past year, IMNN TTM earnings before interest, taxes, depreciation & amortization has changed by +$8.24 M (+29.15%)